Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000886744-19-000039
Filing Date
2019-03-28
Accepted
2019-03-28 20:20:40
Documents
2
Period of Report
2019-03-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1502
2 POWER OF ATTORNEY FOR DAWN C. BIR poa_bir.htm EX-24 2979
  Complete submission text file 0000886744-19-000039.txt   5971
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DRIVE, SUITE 150 IRVING TX 75063
Business Address
Bir Dawn Carter (Reporting) CIK: 0001688712 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-20859 | Film No.: 19713580